The insurer said in a statement to Fierce Healthcare that it will no longer cover GLP-1s in its large group fully insured plans as of Jan
Studies of the same species also varied, with a follow-up of patients treated with GLP-1RAs (74) showing no significant difference in calcitonin concentrations between liraglutide and placebo and no change in the risk of thyroid C-cell tumors
As we will see, this distinction drives very different treatment approaches (Ojo et al., 2023)
Among the plethora of novel agents against diabetes, GLP-1RAs are known to exert various biological effects in extra-pancreatic tissues beyond controlling hyperglycemia ( via central mechanisms ( Similarly, SGLT-2is, also referred to as gliflozins, represent another class of anti-hyperglycemic agents currently used in T2D treatment with favorable effects on body weight
Do GLP-1 Receptor Agonists Increase the Risk of Breast Cancer
Da fr du maksimalt utbytte av tiden din, uansett om du spiller noen f spinn i uken eller foretrekker lengre kter i helgene